Bicycle Therapeutics (BCYC) Share-based Compensation: 2018-2025
Historic Share-based Compensation for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to $8.8 million.
- Bicycle Therapeutics' Share-based Compensation fell 4.68% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 7.27%. This contributed to the annual value of $38.1 million for FY2024, which is 17.26% up from last year.
- Latest data reveals that Bicycle Therapeutics reported Share-based Compensation of $8.8 million as of Q3 2025, which was down 7.04% from $9.4 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Share-based Compensation ranged from a high of $10.3 million in Q4 2024 and a low of $2.6 million during Q2 2021.
- Over the past 3 years, Bicycle Therapeutics' median Share-based Compensation value was $9.2 million (recorded in 2024), while the average stood at $8.9 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Share-based Compensation skyrocketed by 166.89% in 2022, and later declined by 11.34% in 2023.
- Quarterly analysis of 5 years shows Bicycle Therapeutics' Share-based Compensation stood at $3.0 million in 2021, then skyrocketed by 84.73% to $5.5 million in 2022, then spiked by 41.01% to $7.8 million in 2023, then surged by 32.27% to $10.3 million in 2024, then declined by 4.68% to $8.8 million in 2025.
- Its last three reported values are $8.8 million in Q3 2025, $9.4 million for Q2 2025, and $9.6 million during Q1 2025.